Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

ClinicalTrials.gov ID: NCT03616964

Public ClinicalTrials.gov record NCT03616964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 8:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus

Study identification

NCT ID
NCT03616964
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
778 participants

Conditions and interventions

Interventions

  • Baricitinib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2018
Primary completion
Sep 23, 2021
Completion
Oct 19, 2021
Last update posted
Nov 22, 2022

2018 – 2021

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
University of Arizona Arthritis Center Gilbert Arizona 85297
Arizona Arthritis & Rheumatology Research Phoenix Arizona 85302
Arizona Arthritis & Rheumatology Associates, P. C. Tucson Arizona 85704
Wallace Rheumatic Studies Center Beverly Hills California 90211
Medvin Clinical Research - Weidmann Covina California 91722
Office: Dr Robin K Dore Tustin California 92780
Inland Rheumatology & Osteoporosis Medical Group Upland California 91786
Denver Arthritis Clinic - Lowry Denver Colorado 80230
Clinical Research of West Florida, Inc. (Clearwater) Clearwater Florida 33765
Millennium Research Ormond Beach Florida 32174
Integral Rheumatology & Immunology Specialists Plantation Florida 33324
Clinical Research of West Florida Tampa Florida 33603
Tampa Medical Group, P.A. Tampa Florida 33614
Emory University Atlanta Georgia 30322
Northside Hospital Atlanta Georgia 30342
North Georgia Rheumatology, PC Lawrenceville Georgia 30046
Arthritis Center of Lexington Lexington Kentucky 40504
Johns Hopkins University School of Medicine Baltimore Maryland 21224-6801
Advanced Rheumatology, PC Lansing Michigan 48910
Glacier View Research Institute - Endocrinology Kalispell Montana 59901
Innovative Health Research Las Vegas Nevada 89128
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102
Arthritis and Osteoporosis Associates of New Mexico Las Cruces New Mexico 88011
St. Lawrence Health System Canton New York 13617
New York University Medical Center New York New York 10016
SUNY Upstate Medical University Syracuse New York 13210
Joint and Muscle Medical Care Charlotte North Carolina 28204
Box Arthritis & Rheumatology of the Carolinas, PLLC Charlotte North Carolina 28210
Cincinnati Rheumatic Disease Study Group Cincinnati Ohio 45242
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104
Clinical Research Center of Reading,LLC Wyomissing Pennsylvania 19610
Articularis Healthcare d/b/a/ Low Country Rheumatology, PA Summerville South Carolina 29486
Eagle Medical Crossville Tennessee 38555
Dr. Dhiman Basu Private Practice Colleyville Texas 76034
Metroplex Clinical Research Center Dallas Texas 75231
Advanced Rheumatology of Houston The Woodlands Texas 77382
Clear Lake Specialties Webster Texas 77598
Arthritis Clinic of Northern VA, P.C. Arlington Virginia 22205
Spectrum Medical Inc. Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 120 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03616964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2022 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03616964 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →